Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Schering-Plough's Nasonex approved in U.K. and France

April 15, 1997

Nasacort now available for the treatment of allergic rhinitis

April 15, 1997

Fluoxetine for the management of premature ejaculation

April 15, 1997

Lilly reports compounds for postmenopausal syndrome

April 15, 1997

Pharmacia & Upjohn introduces new GH delivery device

April 14, 1997

First CFC-free inhaler launched in U.S.

April 14, 1997

Tentative approval for Faulding's generic aciclovir for injection

April 14, 1997

Wyeth-Ayerst and Elan develop new formulation of Lodine

April 11, 1997

Aldara approved in U.S.

April 11, 1997

First launch for new indication of cabergoline

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...